What condition is NOT a potential adverse effect of Sodium Bicarbonate therapy?

Sodium Bicarbonate therapy is primarily used to treat acidosis and can lead to a variety of adverse effects. Among the options provided, cardiac arrest is not considered a potential adverse effect specifically related to Sodium Bicarbonate therapy.

Metabolic alkalosis can occur as an adverse effect because the administration of Sodium Bicarbonate can increase the body's bicarbonate levels, leading to alkalosis. This happens when there is an accumulation of bicarbonate ions in the blood, resulting in a higher pH than normal.

Hypokalaemia is another potential adverse effect. Sodium Bicarbonate can lead to a shift of potassium ions from the extracellular space to the intracellular space, decreasing serum potassium levels and potentially leading to symptoms associated with low potassium, such as muscle weakness or arrhythmias.

Heart failure can complicate the situation, particularly in patients who are already compromised; however, it does not directly arise as an adverse effect specifically due to the administration of Sodium Bicarbonate. Rather, it pertains to a pre-existing condition that may be exacerbated by fluid retention or shifts in electrolytes but is not caused solely by the therapy itself.

Thus, cardiac arrest is chosen as it does not represent a direct adverse effect of Sodium Bicarbonate therapy, while all the